Cargando…

Corticosteroid Uptake For COVID-19 after Publication of RECOVERY: A Difference in Difference Model

Detalles Bibliográficos
Autores principales:	Kearney, Christopher, Lesieur, Mallory, Bosch, Nicholas A., Walkey, Allan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993153/ https://www.ncbi.nlm.nih.gov/pubmed/36525470 http://dx.doi.org/10.1513/AnnalsATS.202208-715RL

Ejemplares similares

Changes to Hospital Availability of Prone Positioning after the COVID-19 Pandemic
por: Audhya, Xaver, et al.
Publicado: (2022)

Estimating the Impact of COVID-19 on Invasive Mechanical Ventilation Trends in the United States
por: Rucci, Justin M., et al.
Publicado: (2022)

Validation of the International Classification of Diseases Code for COVID-19 among Critically Ill Patients
por: Bosch, Nicholas A., et al.
Publicado: (2022)

Sex differences in response to adjunctive corticosteroid treatment for patients with septic shock
por: Thompson, Kelly, et al.
Publicado: (2021)

Efficacy and safety of different doses of a slow release corticosteroid implant for macular edema
por: Hall, John
Publicado: (2016)

Practice Changes Among Patients Without COVID-19 Receiving Mechanical Ventilation During the Early COVID-19 Pandemic
por: Shankar, Divya A., et al.
Publicado: (2023)

Public Preferences for Policies to Promote COVID-19 Vaccination Uptake
por: Sookarodee, Pathum, et al.
Publicado: (2023)

Recovery of High Degree Atrioventricular Block in a Patient with Cardiac Sarcoidosis by Corticosteroid Therapy
por: Park, Hyukjin, et al.
Publicado: (2018)

Impact of late administration of corticosteroids in COVID-19 ARDS
por: Mongardon, Nicolas, et al.
Publicado: (2020)

IGRA test for TB in COVID-19: role of corticosteroids
por: Granozzi, B., et al.
Publicado: (2022)

Corticosteroids and rehabilitation in COVID-19 survivors
por: Lal, Amos, et al.
Publicado: (2021)

Public perception and performance of different sampling approaches for the diagnosis of COVID‐19
por: Tsang, Ngai Yung, et al.
Publicado: (2021)

Differences in HADS and SF-36 scores 1 year after critical illness in COVID-19 patients
por: Tallarico, Roberta Teixeira, et al.
Publicado: (2022)

A case of shock after 10 days systemic corticosteroid therapy for COVID-19
por: Uemura, Keiko, et al.
Publicado: (2021)

Evaluation of leukopenia during sepsis as a marker of sepsis-defining organ dysfunction
por: Belok, Samuel H., et al.
Publicado: (2021)

A reappraisal of corticosteroids use for COVID-19
por: Pati, Ilaria, et al.
Publicado: (2022)

Early administration of corticosteroids and mortality
por: Sprung, Charles L, et al.
Publicado: (2012)

Use of Corticosteroid in Persistent Post–COVID-19 Interstitial Lung Disease
por: Khaw, Chuen R., et al.
Publicado: (2021)

Sex differences and the role of IL-10 in ischemic stroke recovery
por: Conway, Sarah E., et al.
Publicado: (2015)

COMMENTARY ON: COMPARISON OF OUTCOMES OF TWO DIFFERENT CORTICOSTEROID INJECTION APPROACHES FOR PRIMARY FROZEN SHOULDER: A RANDOMIZED CONTROLLED STUDY
por: UR-REHMAN, Atiq, et al.
Publicado: (2023)

Variation in Troponin I Measurement and the Cardiovascular Management Approach Following Elevated Troponin I Among Critically Ill Patients With Sepsis
por: Garcia, Michael A., et al.
Publicado: (2023)

Antenatal corticosteroids and COVID-19: balancing benefits and harms
por: Liauw, Jessica, et al.
Publicado: (2020)

Unresolved questions about the treatment of COVID-19 with corticosteroids()
por: Corral-Gudino, Luis, et al.
Publicado: (2021)

COVID-19, corticosteroids and public health: a reappraisal
por: Fernandes, M., et al.
Publicado: (2021)

Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences
por: Kamińska, Dorota, et al.
Publicado: (2022)

Prognostic value of lymphocyte count in severe COVID-19 patients with corticosteroid treatment
por: Lu, Chenyang, et al.
Publicado: (2021)

Bullous pemphigoid triggered by COVID‐19 vaccine: Rapid resolution with corticosteroid therapy
por: Dell'Antonia, Massimo, et al.
Publicado: (2021)

Corticosteroids in H1N1, non-viral, and COVID-19 ARDS
por: Kwon, Kyoung-Eun, et al.
Publicado: (2022)

Iatrogenic Kaposi's sarcoma caused by corticosteroids
por: Lazzarini, Rosana, et al.
Publicado: (2016)

Gender-specific differences in outcome after trauma may be explained by differences in immunity
por: Eijk, Lucas T van, et al.
Publicado: (2014)

Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19
por: Zhou, Zhi-Guo, et al.
Publicado: (2020)

Science and the COVID-19 recovery fund: The time for public health and international health diplomacy?!
por: Fischer, Florian
Publicado: (2021)

Use of corticosteroid injections in current COVID pandemic – Time to rethink!!
por: Rajakulasingam, Ramanan, et al.
Publicado: (2020)

Adjuvant corticosteroid therapy for critically ill patients with COVID-19
por: Lu, Xiaofan, et al.
Publicado: (2020)

Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience
por: Adir, Yochai, et al.
Publicado: (2022)

Corticosteroids for Non-severe COVID-19: Primum Non Nocere
por: Muthu, Valliappan, et al.
Publicado: (2022)

The association between corticosteroids and aspergillosis among COVID-19 patients
por: Chang, Yi-Hsin, et al.
Publicado: (2023)

Hypopigmentation and subcutaneous fat, muscle atrophy after local corticosteroid injection
por: Park, Sun-Kyung, et al.
Publicado: (2013)

Health Care Utilization Determined From Administrative Claims Analysis for Patients Who Received Inhaled Corticosteroids With Either Montelukast or Salmeterol
por: Markson, Leona E., et al.
Publicado: (2006)

Potential for overuse of corticosteroids and vasopressin in septic shock
por: Hsu, Joe L, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_s9vjvl9fot513745t7hjtr45da